Topiramate and Developmental delay - a phase IV clinical study of FDA data
Summary:
Developmental delay is reported as a side effect among people who take Topiramate (topiramate), especially for people who are male, 0-1 old, have been taking the drug for 6 - 12 months also take Keppra, and have Infantile spasms.
The phase IV clinical study analyzes which people have Developmental delay when taking Topiramate. It is created by eHealthMe based on reports of 48,099 people who have side effects when taking Topiramate from the FDA, and is updated regularly.
What is Topiramate?
Topiramate has active ingredients of topiramate. It is often used in migraine. eHealthMe is studying from 49,809 Topiramate users. Check the latest studies of Topiramate.
What is Developmental delay?
Developmental delay is found to be associated with 360 drugs and 428 conditions by eHealthMe. Check the latest studies of Developmental delay.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
48,099 people reported to have side effects when taking Topiramate.
Among them, 82 people (0.17%) have Developmental delay.

Among these 82 people:
How long have people been on Topiramate when they have Developmental delay? *
- < 1 month: 0.0 %
- 1 - 6 months: 16.67 %
- 6 - 12 months: 83.33 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Developmental delay when taking Topiramate? *
- female: 25.37 %
- male: 74.63 %
What is the age of people who have Developmental delay when taking Topiramate? *
- 0-1: 53.85 %
- 2-9: 23.08 %
- 10-19: 0.0 %
- 20-29: 11.54 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 3.85 %
What are other drugs people take besides Topiramate? *
- Keppra: 19 people, 23.17%
- Levetiracetam: 14 people, 17.07%
- Valproic Acid: 14 people, 17.07%
- Lamotrigine: 13 people, 15.85%
- Clonazepam: 12 people, 14.63%
- Onfi: 11 people, 13.41%
- Zonisamide: 10 people, 12.20%
- Aranesp: 10 people, 12.20%
- Clobazam: 10 people, 12.20%
- Cellcept: 10 people, 12.20%
What are other side effects people have besides Developmental delay? *
- Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 30 people, 36.59%
- Bicuspid Aortic Valve: 14 people, 17.07%
- Low Birth Weight Baby: 14 people, 17.07%
- Drug Ineffective: 14 people, 17.07%
- Head Injury: 13 people, 15.85%
- Fall: 13 people, 15.85%
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 13 people, 15.85%
- Speech Disorder Developmental: 13 people, 15.85%
- Respiratory Distress (difficulty in breathing): 12 people, 14.63%
- Wheezing (a high-pitched whistling sound made while you breath): 10 people, 12.20%
What are the existing conditions these people have? *
- Infantile Spasms: 10 people, 12.20%
- Chronic Renal Failure (kidney failure): 5 people, 6.10%
- Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 4 people, 4.88%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 4.88%
- Sciatic Nerve Injury: 3 people, 3.66%
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 3.66%
- Osteoporosis (bones weak and more likely to break): 2 people, 2.44%
- Chronic Kidney Disease: 2 people, 2.44%
- Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 1.22%
- Complex Partial Seizures (epileptic seizure): 1 person, 1.22%
* Approximation only. Some reports may have incomplete information.
Do you take Topiramate and have Developmental delay?
- Check whether Developmental delay is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Topiramate:
- Topiramate (49,809 reports)
Developmental delay treatments and more:
- Developmental delay (12,601 reports)
How severe was Developmental delay and when was it recovered:
Expand to all the drugs that have ingredients of topiramate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Topiramate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Developmental delay:
- Developmental delay (360 drugs)
Browse all the conditions that are associated with Developmental delay:
- Developmental delay (428 conditions)
Related publications that referenced our studies
- Baloch M, Siddiqui MA, "Topiramate induced sudden loss of vision", JPMA, 2012 Oct .
- Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .
- Baloch M, Siddiqui MA, "Topiramate induced sudden loss of vision", JPMA, 2012 Oct .
- Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on topiramate (the active ingredients of Topiramate) and Topiramate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Promethazine cause Gastrointestinal Infection? - now
- Schizophrenia and Arteriosclerosis Coronary Artery - 8 seconds ago
- Could Prochlorperazine cause Injection Site Haemorrhage? - 26 seconds ago
- Could Chromium Chloride cause Bleeding Into The Skin? - 30 seconds ago
- Could Prilosec cause Urinary Tract Infection Enterococcal? - 35 seconds ago
- Could Prevacid cause Brain Scan Abnormal? - 46 seconds ago
- Could Prevacid cause Eczema Asteatotic? - 46 seconds ago
- Drug interactions of Spironolactone and Flonase Allergy Relief - 55 seconds ago
- Could Prezcobix cause Heart Attack? - 57 seconds ago
- Lopurin and Pharyngitis for Women aged 40-49 - a minute ago